https://www.marketscreener.com/quote/stock/EXELIXIS-INC-9235/news/Exelixis-Announces-Final-Results-from-Phase-3-COSMIC-311-Pivotal-Trial-of-CABOMETYX-in-Patients-wi-36476254/?utm_source=telegram&utm_medium=social&utm_campaign=share